MGMTAI Trademark

Trademark Overview

On Thursday, April 3, 2025, a trademark application was filed for MGMTAI with the United States Patent and Trademark Office. The USPTO has given the MGMTAI trademark a serial number of 99119821. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, April 3, 2025. This trademark is owned by Caris MPI, Inc.. The MGMTAI trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical analysis of genomic and transcriptomic data using artificial intelligence to predict promoter methylation of the MGMT (O6-methylguanine-DNA methyltransferase ) gene and therapeutic response of cancers to related therapies.

Medical research services in the field of cancer treatment; providing medical research information, namely, using artificial intelligence to predict promoter methylation of the MGMT (O6-methylguanine-DNA methyltransferase ) gene and therapeutic response of cancers to related therapies.
mgmtai

General Information

Serial Number99119821
Word MarkMGMTAI
Filing DateThursday, April 3, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, April 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical analysis of genomic and transcriptomic data using artificial intelligence to predict promoter methylation of the MGMT (O6-methylguanine-DNA methyltransferase ) gene and therapeutic response of cancers to related therapies.
Goods and ServicesMedical research services in the field of cancer treatment; providing medical research information, namely, using artificial intelligence to predict promoter methylation of the MGMT (O6-methylguanine-DNA methyltransferase ) gene and therapeutic response of cancers to related therapies.

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 3, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 3, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCaris MPI, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrving, TX 75039

Trademark Events

Event DateEvent Description
Thursday, April 3, 2025NEW APPLICATION ENTERED
Thursday, April 3, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 3, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

mgmtai medical therapeutic gene response methylguanine cancers research therapies related mgmt